Aug 16, 2025 • Benzinga
BULLISH
Billionaire Investor Buys Google And This Gold Miner Stock - Perpetua Resources ( NASDAQ:PPTA )
John Paulson's hedge fund, Paulson & Co., discloses the purchase of 9,000 shares of Alphabet. The also increases its position in gold miner Perpetua Resources. Get the latest proven ETF strategies to target and profit from summer volatility before the next big market swing.
Aug 15, 2025 • Benzinga
BULLISH
Icahn Hedge Fund's Q2 Moves: Centuri Stake Soars, JetBlue Held, 2 Positions Exited - SandRidge Energy ( NYSE:SD ) , JetBlue Airways ( NASDAQ:JBLU ) , Centuri Holdings ( NYSE:CTRI ) , Intl Flavors & Fragrances ( NYSE:IFF )
Icahn boosts Centuri stake 158%, keeps JetBlue and utilities steady. Portfolio shifts favor infrastructure, utilities, and cash flow over cyclical or speculative bets. Get more market-moving news first with AI-powered analysis that turns noise into opportunity.
Aug 06, 2025 • Benzinga
SOMEWHAT-BULLISH
Global Medical Aesthetic Devices Market to Reach $37.9 Billion by 2029
Boston, Aug. 06, 2025 ( GLOBE NEWSWIRE ) -- As global demand for aesthetic enhancement rises, medical aesthetic devices are transforming how patients approach cosmetic care.
Jul 31, 2025 • Benzinga
SOMEWHAT-BULLISH
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of DURECT Corporation ( NASDAQ: DRRX )
NEW YORK, July 31, 2025 ( GLOBE NEWSWIRE ) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC ( the "M&A Class Action Firm" ) , has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.
Jul 31, 2025 • Zacks Commentary
NEUTRAL
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat
BHC stock falls 6.3% as Q2 earnings miss estimates despite stronger sales and growth in key segments like Salix and Solta Medical.
Jul 31, 2025 • Motley Fool
SOMEWHAT-BULLISH
Bausch Lomb ( BLCO ) Q2 Revenue Rises 5%
Bausch + Lomb ( NYSE:BLCO ) , a global eye health company known for its contact lenses, surgical devices, and eye pharmaceuticals, released results for the second quarter of fiscal 2025 on July 30, 2025. The main headline from the release is GAAP revenue growth of 5% year over year to $1.278 ...